Different rules, different results: patent litigation after In re Baxter

Author： Vogel Bryan J   Roberg-Perez Sharon E  

Publisher： Future Science

ISSN： 2046-8954

Source： Pharmaceutical Patent Analyst, Vol.2, Iss.3, 2013-05, pp. : 295-297

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmaceutical patent litigation in Europe

By Cook T.  

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 2, 1999-02 ,pp. : 181-187

Informa Healthcare

Access to resources Recommend Favorite

Preliminary injunctions in generic and branded patent litigation

By Cohen Simon   England Paul  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 9, 2013-09 ,pp. : 1083-1086

Informa Healthcare

Access to resources Recommend Favorite

Re-operation after Lumbar Disc Surgery: Results in 85 Cases

By Kayaoglu CR   Calikoğlu C   Binler S  

The Journal of International Medical Research, Vol. 31, Iss. 4, 2003-07 ,pp. : 318-323

Field House Publishing

Access to resources Recommend Favorite

The ITC as an attractive patent litigation forum for the biotechnology and pharmaceutical industry

By Burton Carlyn A   Margonis Lisa E  

Pharmaceutical Patent Analyst, Vol. 2, Iss. 2, 2013-03 ,pp. : 177-180

Future Science

Access to resources Recommend Favorite

Reduction of lipid peroxidation in different rat brain areas after cabergoline treatment

By Finotti N.   Castagna L.   Moretti A.   Marzatico F.  

Pharmacological Research, Vol. 42, Iss. 4, 2000-10 ,pp. : 287-291

Academic Press

Access to resources Recommend Favorite